These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29891662)

  • 1. Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
    Tang YA; Chen YF; Bao Y; Mahara S; Yatim SMJM; Oguz G; Lee PL; Feng M; Cai Y; Tan EY; Fong SS; Yang ZH; Lan P; Wu XJ; Yu Q
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5990-E5999. PubMed ID: 29891662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia Tumor Microenvironment Activates GLI2 through HIF-1
    Huang K; Zhang X; Hao Y; Feng R; Wang H; Shu Z; Li A; Du M
    Comput Math Methods Med; 2022; 2022():2032895. PubMed ID: 35186110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic tumor microenvironment in advanced retinoblastoma.
    Sudhakar J; Venkatesan N; Lakshmanan S; Khetan V; Krishnakumar S; Biswas J
    Pediatr Blood Cancer; 2013 Oct; 60(10):1598-601. PubMed ID: 23804414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells.
    He X; Wang J; Wei W; Shi M; Xin B; Zhang T; Shen X
    Cancer Biol Ther; 2016; 17(2):188-98. PubMed ID: 26785721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
    Kaidi A; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer.
    Qiu Y; Zheng H; Sun LH; Peng K; Xiao WD; Yang H
    World J Gastroenterol; 2015 Dec; 21(48):13447-56. PubMed ID: 26730155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α in colorectal carcinoma: review of the literature.
    Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
    J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells.
    Tan Z; Huang Q; Zang J; Teng SF; Chen TR; Wei HF; Song DW; Liu TL; Yang XH; Fu CG; Hu ZQ; Zhou W; Yan WJ; Xiao JR
    Oncotarget; 2017 Apr; 8(16):25885-25896. PubMed ID: 27121066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia.
    Wang X; Wang Y; Li L; Xue X; Xie H; Shi H; Hu Y
    Oncogene; 2020 Feb; 39(9):1860-1874. PubMed ID: 31784651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.
    Page JM; Merkel AR; Ruppender NS; Guo R; Dadwal UC; Cannonier S; Basu S; Guelcher SA; Sterling JA
    Biomaterials; 2015 Sep; 64():33-44. PubMed ID: 26115412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance.
    Lamberti MJ; Rettel M; Krijgsveld J; Rivarola VA; Rumie Vittar NB
    Cell Oncol (Dordr); 2019 Apr; 42(2):173-196. PubMed ID: 30756254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, -10 and -11.
    Su Y; Liu J; Tian Y; Dong H; Shi M; Zhang J; Li W; Huang Q; Xiang N; Wang C; Liu J; He L; Hu L; Haberman AM; Liu H; Yang X
    Biomed Pharmacother; 2024 Apr; 173():116427. PubMed ID: 38484558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment.
    Ciszewski WM; Sobierajska K; Wawro ME; Klopocka W; Chefczyńska N; Muzyczuk A; Siekacz K; Wujkowska A; Niewiarowska J
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2283-2296. PubMed ID: 28893556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.